Login / Signup

Cost-effectiveness of an intervention to reduce fear of cancer recurrence: The ConquerFear randomized controlled trial.

Sophy Ting-Fang ShihPhyllis N ButowSteven J BoweBelinda ThewesJane M TurnerJemma GilchristCathrine Mihalopoulosnull null
Published in: Psycho-oncology (2019)
The ConquerFear intervention is associated with a modest cost and may provide good value for money, but further evidence is needed. Long-term cost-effectiveness needs further investigation to capture full benefits from the intervention beyond the trial follow-up.
Keyphrases
  • randomized controlled trial
  • study protocol
  • clinical trial
  • papillary thyroid
  • phase ii
  • meta analyses